Streetbeat News

Corporate Responsibility

BODI

Beachbody is winding down its MLM network and reaffirming its Q3 financial guidance with expected revenue between $97M and $107M. The company anticipates $54M in annualized overhead savings, reducing its revenue break-even point significantly.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 9:21 pm

BODI

Beachbody has announced a significant reduction in its workforce by approximately 33% as part of a cost-cutting strategy. The company is also broadening its distribution channels to improve its market reach.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 9:16 pm

DUK

Duke Energy has successfully restored power to 1.35 million customers in the Carolinas after outages caused by Hurricane Helene. This demonstrates the company's resilience and capability in handling large-scale disruptions.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 9:11 pm

AGR

Avangrid has fully implemented its return-to-office policy, ending remote work arrangements from the COVID-19 pandemic. This has resulted in a 70% increase in office occupancy. The company has also expanded commuter benefits and committed to sustainable transportation incentives.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 8:45 pm

KBH

KB Home's CFO, Jeff J. Kaminski, will retire in early 2025 after over 14 years in the role. He will remain CFO through the filing of the 2024 Annual Report and assist in the transition. KB Home is currently identifying his successor.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 8:37 pm

TSE

Trinseo is restructuring to enhance growth and profitability, exiting virgin polycarbonate production in Germany. This move will consolidate business units, reduce workforce, and result in significant cost savings and profitability improvements.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 8:19 pm

PDM

Piedmont Office Realty Trust has appointed Sherry Rexroad as its new Chief Financial Officer. This leadership change could influence the company's financial strategies and operations.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 8:16 pm

IGMS

IGMS Biosciences shares fell after the company announced a strategic shift to focus solely on autoimmunity, appointing Beth Harler as CEO. The company will reduce its workforce and cut R&D spending on oncology projects.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 8:14 pm

IGMS

IGM Biosciences is reducing its workforce and minimizing spending on oncology research, including aplitabart, to focus on autoimmunity. Key executives are stepping down, and the company expects its cash runway to extend into 2027.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 8:06 pm

IGMS

IGM Biosciences has announced a strategic shift to focus exclusively on autoimmune diseases and appointed Mary Beth Harler as the new CEO. The company's lead candidates include imvotamab and IGM-2644, targeting conditions like rheumatoid arthritis and generalized myasthenia gravis.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 8:03 pm